Pulsion Medical Systems (PUS.MU) Stock Price
Pulsion Medical Systems Price
Revenue has compounded at 3.7% per year over the past 19 years to 39.99 M EUR. Pulsion Medical Systems's net margin stands at 1.4%, broadly stable from 0.4% several years earlier. The payout ratio is around 6% of earnings. The dividend has grown at 10.3% per year over the past 11 years.
Pulsion Medical Systems stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Pulsion Medical Systems over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Pulsion Medical Systems stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Pulsion Medical Systems's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Pulsion Medical Systems Price |
|---|
Pulsion Medical Systems Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Pulsion Medical Systems Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM EUR |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM EUR |
| EBITM EUR |
| EBIT MARGIN% |
| NET INCOMEM EUR |
| NET INCOME GROWTH% |
| DIVIDENDDIV.EUR |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.00 | 31.00 | 32.00 | 34.00 | 36.00 | 31.00 | 25.00 | 24.00 | 25.00 | 24.00 | 25.00 | 32.00 | 27.00 | 29.00 | 35.00 | 39.00 |
| 3.70 | 10.71 | 3.23 | 6.25 | 5.88 | -13.89 | -19.35 | -4.00 | 4.17 | -4.00 | 4.17 | 28.00 | -15.63 | 7.41 | 20.69 | 11.43 |
| 85.71 | 77.42 | 75.00 | 70.59 | 66.67 | 64.52 | 56.00 | 54.17 | 60.00 | 58.33 | 56.00 | 56.25 | 51.85 | 51.72 | 34.29 | 61.54 |
| 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 20.00 | 14.00 | 13.00 | 15.00 | 14.00 | 14.00 | 18.00 | 14.00 | 15.00 | 12.00 | 24.00 |
| 2.00 | 5.00 | 6.00 | 9.00 | 10.00 | 8.00 | 36.00 | 3.00 | 6.00 | 6.00 | 4.00 | 9.00 | 6.00 | 7.00 | 4.00 | 15.00 |
| 7.14 | 16.13 | 18.75 | 26.47 | 27.78 | 25.81 | 144.00 | 12.50 | 24.00 | 25.00 | 16.00 | 28.13 | 22.22 | 24.14 | 11.43 | 38.46 |
| – | 2.00 | 4.00 | 7.00 | 7.00 | 5.00 | 35.00 | – | – | – | – | – | 1.00 | – | -2.00 | – |
| – | – | 100.00 | 75.00 | – | -28.57 | 600.00 | – | – | – | – | – | – | – | – | – |
| – | – | – | – | 0.30 | 0.04 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.88 | 0.88 | 0.88 | 0.88 |
| – | – | – | – | – | -86.67 | 2,050.00 | – | – | – | – | – | 2.33 | – | – | – |
| 8.25 | 8.25 | 8.25 | 8.25 | 8.25 | 8.25 | 8.25 | 8.25 | 8.25 | 8.25 | 8.25 | 8.25 | 8.25 | 8.25 | 8.25 | 8.25 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Pulsion Medical Systems generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Pulsion Medical Systems retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Pulsion Medical Systems's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Pulsion Medical Systems has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Pulsion Medical Systems's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Pulsion Medical Systems stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Pulsion Medical Systems Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Pulsion Medical Systems business model & stock analysis
Pulsion Medical Systems SWOT Analysis
Strengths
Pulsion Medical Systems SE has a strong brand reputation in the medical industry.
The company offers a diverse range of high-quality medical devices and solutions.
Pulsion Medical Systems SE has a robust distribution network, enabling easy access to its products globally.
Weaknesses
The company relies heavily on a limited number of key suppliers, which may pose a risk to its supply chain.
Pulsion Medical Systems SE lacks diversification in terms of its product portfolio.
The company faces intense competition from larger, more established players in the medical systems market.
Opportunities
Growing demand for advanced medical technologies presents opportunities for Pulsion Medical Systems SE to expand its market share.
Increasing healthcare expenditure in emerging markets provides the company with potential for significant revenue growth.
The development of innovative medical solutions and partnerships with research institutions can drive further growth for Pulsion Medical Systems SE.
Threats
Stringent government regulations and compliance requirements in the medical industry pose a challenge for Pulsion Medical Systems SE.
Currency fluctuations and economic uncertainties can impact the company's financial performance, especially in international markets.
The emergence of new competitors and disruptive technologies may disrupt Pulsion Medical Systems SE's market position.
Pulsion Medical Systems Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Pulsion Medical Systems historical P/E ratio, EBIT multiple, and P/S ratio
Pulsion Medical Systems annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Pulsion Medical Systems shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Pulsion Medical Systems Dividend History
13 years of dividend payments
Pulsion Medical Systems dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Pulsion Medical Systems Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 3/23/2007 | 0.03EUR | - | 6.71 MEUR | - | 2006 Q4 |
Pulsion Medical Systems shareholder structure
| % | Name |
|---|---|
0.00000% | |
0.00000% |
Pulsion Medical Systems Executives and Management Board
7 members · 14 % women
Management
Mr. Lars Mattsson
Head of Investor Relations · since 2021
Board of Directors
Dr. Jens Viebke
Chairman of the Board · since 2014
Mr. Michael Vallon
Vice Chairman of the Board · since 2015
Mr. Stephan Haft
Member of the Executive Board
Dr. Sergej Kammerzell
Member of the Executive Board
Ms. Elin Frostehav
Director
Mr. Niclas Sjoeswaerd
Director
Frequently asked questions about Pulsion Medical Systems
The business model of Pulsion Medical Systems SE is focused on providing innovative medical devices and solutions for critical care patients. The company specializes in hemodynamic monitoring and offers a comprehensive portfolio of products designed to optimize patient management in various healthcare settings. Pulsion Medical Systems SE aims to improve patient outcomes by delivering advanced technologies that enable accurate and continuous measurement of key physiological parameters. Their products, supported by extensive research and development, are used by doctors and healthcare professionals worldwide to enhance clinical decision-making and optimize patient care. Pulsion Medical Systems SE is committed to advancing critical care medicine through their cutting-edge products and expertise.
Pulsion Medical Systems SE is primarily active in the medical devices industry.
The main competitors of Pulsion Medical Systems SE in the market are other companies operating in the medical technology industry. These may include companies like Medtronic, Philips Healthcare, GE Healthcare, Siemens Healthineers, and Baxter International. These competitors also provide a range of medical devices and solutions for healthcare professionals. However, Pulsion Medical Systems SE distinguishes itself through its innovative products, advanced technology, and a strong reputation for quality and reliability. With its unique offerings and dedication to providing cutting-edge medical solutions, Pulsion Medical Systems SE remains a strong player in the competitive market.
Pulsion Medical Systems SE is a renowned medical technology company specializing in the development and manufacturing of advanced monitoring systems. Founded in 1990, the German-based company has been at the forefront of providing innovative solutions to enhance patient care and safety. With a strong focus on hemodynamic monitoring and critical care, Pulsion Medical Systems SE has consistently delivered high-quality products to healthcare professionals worldwide. Their continuous dedication to research and development has enabled the company to offer cutting-edge technologies that improve patient outcomes. With a reputation for excellence, Pulsion Medical Systems SE continues to make significant contributions to the field of medical technology.
Pulsion Medical Systems SE, a renowned healthcare company, has achieved noteworthy milestones throughout its history. With a commitment to innovation and technology, the company has revolutionized the medical industry. Significant accomplishments include the development of advanced diagnostic and therapeutic solutions, pioneering research in critical care monitoring, and the successful introduction of cutting-edge medical devices. Pulsion Medical Systems SE has consistently improved patient outcomes and established itself as a leader in the healthcare sector. Continuously striving for excellence, the company remains dedicated to enhancing medical practices and positively impacting global healthcare standards.
Pulsion Medical Systems SE is primarily present in Germany, where it is headquartered. The company specializes in developing and manufacturing medical devices and solutions for hemodynamic monitoring. With a strong foothold in its home country, Pulsion Medical Systems SE also has a growing presence in various countries and regions around the world. The company aims to expand its reach and deliver innovative healthcare solutions to healthcare professionals and patients globally.
Pulsion Medical Systems SE, a leading company in the medical industry, embodies strong core values and a distinctive corporate philosophy. With a focus on innovation and patient care, Pulsion Medical Systems SE prioritizes excellence in providing advanced medical technologies. Their commitment to superior quality, reliability, and precision reflect their dedication to enhancing healthcare outcomes. As a market leader, Pulsion Medical Systems SE consistently strives for customer satisfaction and continuous improvement. By prioritizing research and development, they continually introduce cutting-edge solutions to meet evolving healthcare needs. With their unwavering emphasis on ethics, integrity, and professionalism, Pulsion Medical Systems SE is a trusted partner in the medical field.
Pulsion Medical Systems SE is a globally active company specialized in the development and production of innovative medical devices. The company's business model is based on providing high-quality medical equipment for a wide range of applications and industries. The company has several business divisions, including patient monitoring, hemodynamic monitoring, vascular access, and dialysis. Each of these divisions focuses on the development of specific products and technologies tailored to the requirements of their respective industries. The patient monitoring division offers a wide range of devices and systems for monitoring vital parameters such as heart rate, blood pressure, and oxygen saturation. These products are specifically designed for use in hospitals, intensive care units, and emergency departments, providing doctors and nursing staff with quick and accurate monitoring of their patients' vital functions. Hemodynamic monitoring focuses on measuring the patient's blood flow and vascular resistance. This technology is particularly essential for monitoring patients with cardiovascular problems, including heart failure and stroke. The vascular access division offers products for establishing intravenous access, required during surgeries, procedures, and other medical interventions. The company has specifically focused on developing products that minimize the risk of complications in setting up IV access, such as vein injuries and infections. The dialysis division provides a variety of products and systems for the treatment of patients with kidney disease. These devices are used in dialysis technology to remove waste products and excess fluid from the patient's bloodstream. To optimize their business model, the company provides a team of sales and customer service professionals who work closely with customers to understand specific requirements and needs and offer tailored solutions. The company has distribution channels in Europe, Asia, the USA, and the Middle East and collaborates with a wide network of resellers to distribute its products worldwide. Overall, Pulsion Medical Systems SE's business model is based on the development of innovative and high-quality medical devices specifically tailored to the needs of hospitals, clinics, and similar facilities. Through targeted advertising and intensive collaboration with customers, the company aims to maintain its business and ensure future growth.
The revenue cannot currently be calculated for Pulsion Medical Systems.
The profit cannot currently be calculated for Pulsion Medical Systems.
The P/E ratio cannot be calculated for Pulsion Medical Systems at the moment.
The P/S cannot be calculated for Pulsion Medical Systems currently.
The Eulerpool Quality Score for Pulsion Medical Systems is 4/10.
The ISIN of Pulsion Medical Systems is DE0005487904. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Pulsion Medical Systems is 548790. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Pulsion Medical Systems is PUS.MU. The ticker symbol is used to trade Pulsion Medical Systems shares on the stock exchange.
The current dividend yield of Pulsion Medical Systems is - %.
Pulsion Medical Systems is assigned to the 'Health' sector.
The dividends of Pulsion Medical Systems are distributed in EUR.
Pulsion Medical Systems stock
Pulsion Medical Systems Peer Group
Pulsion Medical Systems FIGI
All fundamentals and in-depth analysis of Pulsion Medical Systems
Our stock analysis for Pulsion Medical Systems stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pulsion Medical Systems. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.